ANTITHROMBOTIC THERAPY TO AMELIORATE CLINICAL COMPLICATIONS IN COMMUNITY ACQUIRED PNEUMONIA (ATTACC-CAP)

Registry ID

OZM-129

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

UNIVERSITY OF MANITOBA

Start date

2023-10-10

Last update

2023-01-12

Conditions

• COMMUNITY-ACQUIRED PNEUMONIA

Related clinical trials

• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CAL02 ADMINISTERED INTRAVENOUSLY IN ADDITION TO STANDARD OF CARE IN SUBJECTS WITH SEVERE COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (SCABP)
• RANDOMIZED, EMBEDDED, MULTIFACTORIAL ADAPTIVE PLATFORM TRIAL FOR COMMUNITY-ACQUIRED PNEUMONIA (REMAP-CAP)

View on source registry